scholarly journals Omental metastasis with malignant ascites: an unusual manifestation of prostatic adenocarcinoma

2012 ◽  
Vol 1 (3) ◽  
Author(s):  
Sanjeev Madaan, ◽  
Victor Palit ◽  
Patricia Gudgeon ◽  
Chandra Shekhar Biyani
Keyword(s):  
Prostate Gland ◽  
Specific Antigen ◽  
Malignant Ascites ◽  
Prostatic Adenocarcinoma ◽  
Second Line ◽  
Antigen Level ◽  
Review Of The Literature ◽  
Clinical Progression ◽  
Unusual Manifestation ◽  
Omental Metastasis

Omental metastasis with malignant ascites from prostatic adenocarcinoma israre. This case report is about a patient who presented with a 24-hour historyof a swollen right leg. Clinical examination revealed a hard prostate and bloodbiochemistry demonstrated an elevated prostate specific antigen level. A Dopplerultrasound scan excluded deep venous thrombosis, but a CT scan of the abdomen revealed marked para-aortic lymphadenopathy and prostate gland biopsy confirmedprostatic adenocarcinoma. The patient was treated with goserelin. Three years later, he presented with ascites and an omental mass. Histology of theomental mass showed metastasis from the prostatic adenocarcinoma. He was treated with second-line hormonal therapy but died after 4 months. We discuss the clinical progression, with a review of the literature.

scholarly journals Incidental Accumulation of Fluciclovine in Neuroendocrine Tumour in a Patient with Oncological Duplicity

2020 ◽  
Vol 13 (1) ◽  
pp. 431-435 ◽  
Author(s):  
Zuzana Balážová ◽  
Igor Černý ◽  
Petr Vyškovský
Keyword(s):  
Neuroendocrine Tumour ◽  
Prostate Gland ◽  
Specific Antigen ◽  
Newly Diagnosed ◽  
Antigen Level ◽  
Recurrent Prostate Cancer ◽  
Adult Men ◽  
First Case ◽  
Gland Carcinoma ◽  
Pet Radiopharmaceutical

18F-fluciclovine is a PET radiopharmaceutical used for the detection of recurrent prostate cancer in adult men after primary curative treatment with suspicion of recurrence based on elevated prostate-specific antigen level. Several incidental uptakes of 18F-fluciclovine in other tumour types have been described in the literature so far – in breast cancer, hepatocellular carcinoma, and malignant melanoma. Our case report presents a patient with oncological duplicity (prostate gland carcinoma and newly diagnosed neuroendocrine tumour) and with accumulation of fluciclovine in pathologically proved neuroendocrine tumour, later imagined also by octreotide SPECT/CT. To our knowledge, this is the first case of fluciclovine accumulated in a neuroendocrine tumour described in the literature.

scholarly journals The Incidental prostatic adenocarcinoma and transitional cell carcinoma involvement of the prostate gland in patients undergoing radical cystoprostatectomy for bladder cancer treatment in Rajavithi Hospital

2021 ◽  
Vol 42 (2) ◽  
pp. 103-109
Author(s):  
Weerawut Promwattanapan ◽  
◽  
Nattapong Wongwattanasatien ◽  
Keyword(s):  
Bladder Cancer ◽  
Transitional Cell Carcinoma ◽  
Cell Carcinoma ◽  
Prostate Gland ◽  
Transitional Cell ◽  
Specific Antigen ◽  
Digital Rectal Examination ◽  
Prostatic Adenocarcinoma ◽  
Pathological Findings ◽  
Radical Cystoprostatectomy

Objective: To determine the incidence of incidental prostatic adenocarcinoma and transitional cell carcinoma (TCC) involvement of the prostate gland in patients undergoing radical cystoprostatectomy in Rajavithi Hospital, Secondly, to assess the possible influence of the patient factors and bladder cancer on the pathological findings of the prostate gland. Materials and Methods: We retrospectively reviewed 169 male patients who had undergone radical cystoprostatectomy for bladder cancer between April 2013 and August 2019. Pathologic findings of the prostate gland and urothelial cancer in the prostate gland were catalogued. Information including age, body mass index (BMI), underlying disease, glomerular filtration rate (GFR), pathologic stage, and grade was collected and analyzed to determine any correlations. Results: Incidental prostatic adenocarcinoma and TCC involvement of the prostate gland were found in 15 patients (8.9%) and 29 patients (17.2%), respectively. There were no correlations between patient demographics and pathological findings of the prostate gland. Conclusion: Although the incidence of incidental prostatic adenocarcinoma and TCC involvement of the prostate gland in our research is low, the screening of every candidate for prostate sparing cystectomy with a digital rectal examination, prostate-specific antigen, and transurethral biopsy of the prostatic urethra and bladder neck prior to surgery are recommended.

scholarly journals Study of prostatic pathology and its correlation with prostate specific antigen level

2017 ◽  
Vol 7 (1) ◽  
pp. 1074-1077 ◽  
Author(s):  
S Hirachand ◽  
UMS Dangol ◽  
S Pradhanang ◽  
S Acharya
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Prostate Specific Antigen ◽  
Prostate Gland ◽  
Specific Antigen ◽  
Prostatic Hyperplasia ◽  
Prostate Specific Antigen Level ◽  
Transurethral Resection Of Prostate ◽  
Antigen Level ◽  
Histological Lesion ◽  
Serum Prostate Specific Antigen

Background: Diseases primarily inflicting prostate gland are inflammation, benign prostatic hyperplasia and cancer. Prostate specific antigen is a protein produced by the cells of prostate gland. It has been widely used in the diagnosis and management of patients with prostatic cancer. The aim this study was to determine the correlation between serum prostate specific antigen level and histological findings in biopsy specimens of men with prostatic disease.Materials and methods: This study was carried out at Kathmandu Medical College and Teaching Hospital, department of Pathology over a period of 2 years. One hundred and twenty eight cases with prostatic lesions were included in this study. Prostate specific antigen values of these cases were recorded before the surgical process. Histology of the tissue samples collected after transurethral resection of prostate was studied and relationship with prostate specific antigen level were analyzed.Results: Benign prostatic hyperplasia was the most common histological lesion encountered (n=95; 74.22%). Prostatic adenocarcinomas were seen a decade older than those with benign lesions. Maximum number of the benign cases had the Prostate specific antigen range of 0-7ng/ml. Most of the prostatic intraepithelial neoplasia lesions were seen within the PSA range of 0-7ng/ml and adenocarcinoma in the range of >20ng/ml.Conclusion: Prostate specific antigen is specific for the prostate but not for prostate cancer. Both benign and malignant lesions in prostate can cause increase in serum prostate specific antigen levels, but the chances of malignancy it rising level. 

Prostate Gland–like Epithelium in the Epididymis: A Case Report and Review of the Literature

2004 ◽  
Vol 128 (4) ◽  
pp. e60-e62
Author(s):  
Lisa Yan-Jie Lee ◽  
James Tzeng ◽  
Marina Grosman ◽  
Pamela D. Unger
Keyword(s):  
Case Report ◽  
Prostate Specific Antigen ◽  
Prostate Gland ◽  
Specific Antigen ◽  
Immunohistochemical Analysis ◽  
Prostatic Tissue ◽  
Urinary System ◽  
Review Of The Literature ◽  
Male Urethra ◽  
Related Case

Abstract Aberrant prostatic tissue occurs commonly in the adult male urethra and bladder. Ectopic prostatic tissue occurring outside the urinary system is rare. One case with scattered prostate-type glands in epididymis has been reported in the literature. We report a related case, in which the presence of prostate gland–like epithelium was recognized in epididymal glands in routine histology and was confirmed by subsequent immunohistochemical analysis using prostate-specific antigen. We then examined 23 additional orchiectomy specimens for the presence of prostate-like epithelium. The possibility of this being true ectopia versus an unusual metaplastic change is discussed.

36: Management of Patients with Elevated Prostate Specific Antigen Level among General Practitioners in Switzerland

2005 ◽  
Vol 173 (4S) ◽  
pp. 10-11
Author(s):  
Markus Fatzer ◽  
Michael Muentener ◽  
Raeto T. Strebel ◽  
Dieter Hauri ◽  
Hubert A. John
Keyword(s):  
Prostate Specific Antigen ◽  
General Practitioners ◽  
Specific Antigen ◽  
Prostate Specific Antigen Level ◽  
Antigen Level

Social Representations and Commitment

2018 ◽  
Vol 23 (3) ◽  
pp. 233-249 ◽  
Author(s):  
Eric Bonetto ◽  
Fabien Girandola ◽  
Grégory Lo Monaco
Keyword(s):  
Social Representations ◽  
Social Representation ◽  
Second Line ◽  
Review Of The Literature ◽  
First Line ◽  
Research Perspectives ◽  
The Social ◽  
Bibliographic Search ◽  
English Articles

Abstract. This contribution consists of a critical review of the literature about the articulation of two traditionally separated theoretical fields: social representations and commitment. Besides consulting various works and communications, a bibliographic search was carried out (between February and December, 2016) on various databases using the keywords “commitment” and “social representation,” in the singular and in the plural, in French and in English. Articles published in English or in French, that explicitly made reference to both terms, were included. The relations between commitment and social representations are approached according to two approaches or complementary lines. The first line follows the role of commitment in the representational dynamics: how can commitment transform the representations? This articulation gathers most of the work on the topic. The second line envisages the social representations as determinants of commitment procedures: how can these representations influence the effects of commitment procedures? This literature review will identify unexploited tracks, as well as research perspectives for both areas of research.

Sign in / Sign up

Export Citation Format

Share Document